Skip to content

THERABIOGEN, INC.

CIK 0001405286

← back to feed
Revenue (TTM)
$901.06K
+103.9% YoY Q1 May 2012
Net Income (TTM)
−$13.15M
−294.7% YoY Q1 May 2012
EPS Diluted (TTM)
—
Q1 May 2012
Gross Margin
13.8%
Q1 May 2012
Operating Margin
—
Q1 May 2012
Net Margin
-1,459.5%
Q1 May 2012
Free Cash Flow (TTM)
—
Q1 May 2012
Cash
$166
Q1 May 2012
Total Debt
—
Q1 May 2012
Shares Outstanding
71.39M sh
Q1 May 2012

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings